Varje dag samlar vi de senast publicerade vetenskapliga studierna om hampa, CBD och cannabis och sammanfattar kort vad var och en undersökte — på svenska och engelska. Alla länkar går till primärkällan (PubMed, Europe PMC eller ClinicalTrials.gov). Sammanfattningarna är neutrala beskrivningar av vad forskarna studerade, inte hälsopåståenden.
Cannabigerol, a minor phytocannabinoid, prevents behavioral changes induced by psychotomimetic drugs.
Prog Neuropsychopharmacol Biol Psychiatry · 2026 Sep 3 · PubMed
Svenska: Cannabigerol (CBG) is a phytocannabinoid present in the plant Cannabis sativa that, similar to cannabidiol (CBD), does not cause psychotomimetic effects.
Cannabidiol alters the epigenome of hormone-dependent prostate cancer cells.
Biomed Pharmacother · 2026 Sep 3 · PubMed
Svenska: Cannabidiol (CBD) shows promising anti-cancer effects, including reducing proliferation and migration and inducing cell death.
Full-spectrum cannabidiol-rich oil modulates behavior and neurochemical alterations in a rodent model of maple syrup urine disease.
Metab Brain Dis · 2026 Sep 3 · PubMed
Svenska: Maple Syrup Urine Disease (MSUD) is caused by a genetic mutation in the branched-chain α-ketoacid dehydrogenase complex, resulting to accumulation of branched-chain amino acids (BCAAs) that affect the central nervous system and cause neurochemical alterations and behavioral changes.
Cannabigerol and standardized full-spectrum cannabis extract effects in acute and chronic inflammatory pain models.
Psychopharmacology (Berl) · 2026 Sep 3 · PubMed
Svenska: Chronic inflammatory pain is associated with persistent sensory and immune dysregulation.
Role of CBD in Improving Alexithymia
ClinicalTrials.gov (TERMINATED) · 2026-09-01 · ClinicalTrials.gov
Svenska: Given the treatments that are available today for HIV disease, people living with HIV (PLWH) can generally expect good medical outcomes. However, HIV is still a chronic disease and there are remaining barriers to achieving ideal health status and quality of life.
Repeated Administration of Cannabis Varying in THC and CBD
ClinicalTrials.gov (SUSPENDED) · 2026-09-01 · ClinicalTrials.gov
Svenska: The majority of the \>3 million medical cannabis patients in the U.S. use cannabis products to manage pain but many questions remain.
Can Medical Cannabis Affect Opioid Use?
ClinicalTrials.gov (COMPLETED) · 2026-09-03 · ClinicalTrials.gov
Svenska: The goal of this observational study is to learn how medical cannabis (MC) affects pain and the use of opioid pain medications. Participants who have chronic pain and use prescribed opioid pain medication will opt-in to using MC or not for the 3-month study.
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
ClinicalTrials.gov (RECRUITING) · 2026-09-04 · ClinicalTrials.gov
Svenska: This clinical trial is being done to better understand how daily treatment with Tetrahydrocannabinol (THC), Cannabidiol (CBD), or the combination of CBD plus THC affects knee osteoarthritis pain and other related symptoms.